186 related articles for article (PubMed ID: 35864871)
1. Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.
Li J; Yu H; Yao J; Jiang Z; Li Z; Cui X
Oxid Med Cell Longev; 2022; 2022():1747604. PubMed ID: 35864871
[TBL] [Abstract][Full Text] [Related]
2. SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.
Bian Z; Zhou M; Cui K; Yang F; Cao Y; Sun S; Liu B; Gong L; Li J; Wang X; Li C; Yao S; Yin Y; Huang S; Fei B; Huang Z
J Exp Clin Cancer Res; 2021 Nov; 40(1):360. PubMed ID: 34782005
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop.
Wu G; Hao C; Qi X; Nie J; Zhou W; Huang J; He Q
Cell Death Dis; 2020 May; 11(5):393. PubMed ID: 32447342
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis.
Ge BH; Li GC
J Gene Med; 2020 Nov; 22(11):e3247. PubMed ID: 32602607
[TBL] [Abstract][Full Text] [Related]
6. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.
Lu S; Zeng L; Mo G; Lei D; Li Y; Ou G; Wu H; Sun J; Rong C; He S; Zhong D; Ke Q; Zhang Q; Tan X; Cen H; Xie X; Liao C
PLoS One; 2023; 18(11):e0294729. PubMed ID: 37988356
[TBL] [Abstract][Full Text] [Related]
8. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma.
Lin J; Liu Y; Liu P; Qi W; Liu J; He X; Liu Q; Liu Z; Yin J; Lin J; Bao H; Lin J
J Exp Clin Cancer Res; 2023 Dec; 42(1):339. PubMed ID: 38098044
[TBL] [Abstract][Full Text] [Related]
9. SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.
Liu X; Zhang B; Jia Y; Fu M
Cell Cycle; 2020 Mar; 19(6):711-725. PubMed ID: 32089063
[TBL] [Abstract][Full Text] [Related]
10. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():929655. PubMed ID: 35719962
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis.
Wo Q; Zhang D; Hu L; Lyu J; Xiang F; Zheng W; Shou J; Qi X
Biochem Biophys Res Commun; 2019 Dec; 520(3):586-593. PubMed ID: 31623830
[TBL] [Abstract][Full Text] [Related]
13. Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in Regulating Autophagy in Patients with Breast Cancer.
Gu J; Wang Y; Wang X; Zhou D; Wang X; Zhou M; He Z
Cell Physiol Biochem; 2018; 48(1):194-207. PubMed ID: 30007957
[TBL] [Abstract][Full Text] [Related]
14. SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p.
Li W; Zheng Y; Mao B; Wang F; Zhong Y; Cheng D
Biochem Biophys Res Commun; 2020 Dec; 533(4):1435-1441. PubMed ID: 33109341
[TBL] [Abstract][Full Text] [Related]
15. SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis.
Du F; Hou Q
BMC Cancer; 2020 Sep; 20(1):839. PubMed ID: 32883232
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
Zhang ZB; Liu N
Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis.
Tong F; Guo J; Miao Z; Li Z
Cancer Biomark; 2021; 30(1):1-12. PubMed ID: 32924983
[TBL] [Abstract][Full Text] [Related]
19. Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment.
Tang Z; Feng H; Shu L; Guo M; Qi B; Pu L; Shi H; Ren J; Li C
BMC Med Genomics; 2023 May; 16(1):115. PubMed ID: 37231440
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
